These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 2783661

  • 21. Relative production of IL-1 beta and TNF alpha by mononuclear cells after exposure to dental implants.
    Perala DG, Chapman RJ, Gelfand JA, Callahan MV, Adams DF, Lie T.
    J Periodontol; 1992 May; 63(5):426-30. PubMed ID: 1527686
    [Abstract] [Full Text] [Related]

  • 22. Autocrine growth by two cytokines, interleukin-6 and tumor necrosis factor alpha, in the myeloma cell line KHM-1A.
    Hata H, Matsuzaki H, Takatsuki K.
    Acta Haematol; 1990 May; 83(3):133-6. PubMed ID: 2109452
    [Abstract] [Full Text] [Related]

  • 23. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
    Giuliani N, Colla S, Morandi F, Rizzoli V.
    Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
    [Abstract] [Full Text] [Related]

  • 24. Molecular and biological characterization of three novel interleukin-6-dependent human myeloma cell lines.
    Verdelli D, Mattioli M, Fabris S, Nobili L, Intini D, Guerneri S, Todoerti K, Zanella A, Deliliers GL, Lombardi L, Neri A.
    Haematologica; 2005 Nov; 90(11):1541-8. PubMed ID: 16266902
    [Abstract] [Full Text] [Related]

  • 25. Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6.
    Westendorf JJ, Ahmann GJ, Greipp PR, Witzig TE, Lust JA, Jelinek DF.
    Leukemia; 1996 May; 10(5):866-76. PubMed ID: 8656685
    [Abstract] [Full Text] [Related]

  • 26. Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components.
    Zhang Y, Doerfler M, Lee TC, Guillemin B, Rom WN.
    J Clin Invest; 1993 May; 91(5):2076-83. PubMed ID: 7683696
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Bone lesions and macrophage inflammatory protein-1 alpha (MIP-1a) in human multiple myeloma.
    Hata H.
    Leuk Lymphoma; 2005 Jul; 46(7):967-72. PubMed ID: 16019547
    [Abstract] [Full Text] [Related]

  • 35. Observations on the mechanism of bone resorption induced by multiple myeloma marrow culture fluids and partially purified osteoclast-activating factor.
    Josse RG, Murray TM, Mundy GR, Jez D, Heersche JN.
    J Clin Invest; 1981 May; 67(5):1472-81. PubMed ID: 6262378
    [Abstract] [Full Text] [Related]

  • 36. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period.
    Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R.
    Endocrinology; 1995 Jul; 136(7):3054-61. PubMed ID: 7789332
    [Abstract] [Full Text] [Related]

  • 37. Expression of interleukin 1 alpha, interleukin 6, and tumor necrosis factor alpha genes in human melanoma clones is associated with that of mutated N-RAS oncogene.
    Castelli C, Sensi M, Lupetti R, Mortarini R, Panceri P, Anichini A, Parmiani G.
    Cancer Res; 1994 Sep 01; 54(17):4785-90. PubMed ID: 8062279
    [Abstract] [Full Text] [Related]

  • 38. Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines.
    Jernberg H, Pettersson M, Kishimoto T, Nilsson K.
    Leukemia; 1991 Mar 01; 5(3):255-65. PubMed ID: 1707469
    [Abstract] [Full Text] [Related]

  • 39. Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma.
    Filella X, Blade J, Guillermo AL, Molina R, Rozman C, Ballesta AM.
    Cancer Detect Prev; 1996 Mar 01; 20(1):52-6. PubMed ID: 8907203
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.